Clinical application of phototherapy in neonatal jaundice

Birth Defects Original Article Series
|January 1, 1976
PubMed

Insights

Continuous phototherapy is effective for preventing jaundice in low birth weight (LBW) infants. This method showed no long-term negative effects and may require increased metabolic support for infants.

Area of Science:

  • Neonatal Medicine
  • Pediatric Phototherapy Research
  • Infant Health

Background:

  • Neonatal jaundice is a common condition in low birth weight (LBW) infants.
  • Phototherapy is a standard treatment for hyperbilirubinemia in newborns.
  • Optimizing phototherapy protocols is crucial for infant well-being.

Purpose of the Study:

  • To evaluate the efficacy of continuous versus intermittent phototherapy in LBW infants.
  • To assess the impact of phototherapy on infant metabolic requirements.
  • To determine any long-term adverse effects of phototherapy.

Main Methods:

  • Comparison of continuous (12 hours on/12 hours off) and intermittent phototherapy schedules.
  • Monitoring of infant metabolic status during treatment.
  • Long-term follow-up assessment at 2 years of age.

Main Results:

  • Continuous phototherapy demonstrated greater effectiveness in preventing jaundice compared to intermittent therapy.
  • Phototherapy appears to increase the metabolic demands of LBW infants.
  • No detrimental long-term effects were observed up to the 2-year follow-up point.

Conclusions:

  • Continuous phototherapy is a superior treatment for neonatal jaundice in LBW infants.
  • Further research is needed to address potential increases in metabolic requirements during therapy.
  • Phototherapy is a safe treatment with no identified long-term adverse outcomes.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...